Garth Sutherland

Ice Angels was formed in 2004 by five founding members and The Icehouse to enable members to invest collaboratively into Kiwi startups. Ice Angels grew to be among the most active angel investment networks globally comprising over 200 entrepreneurs, executives, and professional investors investing >$10m per year. Ice Angels operation as an independent club was discontinued in 2020 with many of the members becoming active investors in the Icehouse Ventures community.

Adherium Limited (ASX.ADR) is an Global Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Adherium’s Hailie® sensor technology and cloud-based data platform provides real-time feedback on patients use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs. Together with our strategic partners, we are developing new generation technology and working to deliver value to payers and providers, while maximizing the positive reimbursement environment with remote patient monitoring (RPM) payments now in place. Adherium’s Hailie® digital solution comprises patented sensors and proprietary algorithms that track medication delivery, capturing data for clinicians and generating auditable reimbursement reports for payers and providers. • Most clinical evidence of any digital respiratory monitor (>85 studies involving 13,000 patients) • Clinically proven to improve adherence and outcomes • >170,000 devices sold in 30 countries • Widest US inhaler market coverage • Funded technology upgrade will access US reimbursement

Tuhua was the name of Icehouse Ventures first two seed funds. Investments include Halter, Avertana, 90 Seconds, IMeasureU (acquired by LSE: OMG), TNX, Tradify, Parrot Analytics, Mint Innovation, Spalk, Cirrus, Genoapay (acquired by Latitude FS), Melodics, Sharesies, Rocos (acquired by DroneDeploy), Joyous, Vessev, Nilo, Dawn Aerospace, Caruso, Groov, Partly, Dexibit, The Insides Company, Inhibit Coatings, Jettzy, McCarthy Finch (acquired by Onit), Datch, Basis, Upstock, Narrative, Vertus Energy, and Open Star.

Ice Angels was formed in 2004 by five founding members and The Icehouse to enable members to invest collaboratively into Kiwi startups. Ice Angels grew to be among the most active angel investment networks globally comprising over 200 entrepreneurs, executives, and professional investors investing >$10m per year. Ice Angels operation as an independent club was discontinued in 2020 with many of the members becoming active investors in the Icehouse Ventures community.

Adherium Limited (ASX.ADR) is an Global Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Adherium’s Hailie® sensor technology and cloud-based data platform provides real-time feedback on patients use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs. Together with our strategic partners, we are developing new generation technology and working to deliver value to payers and providers, while maximizing the positive reimbursement environment with remote patient monitoring (RPM) payments now in place. Adherium’s Hailie® digital solution comprises patented sensors and proprietary algorithms that track medication delivery, capturing data for clinicians and generating auditable reimbursement reports for payers and providers. • Most clinical evidence of any digital respiratory monitor (>85 studies involving 13,000 patients) • Clinically proven to improve adherence and outcomes • >170,000 devices sold in 30 countries • Widest US inhaler market coverage • Funded technology upgrade will access US reimbursement

Adherium Limited (ASX.ADR) is an Global Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Adherium’s Hailie® sensor technology and cloud-based data platform provides real-time feedback on patients use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs. Together with our strategic partners, we are developing new generation technology and working to deliver value to payers and providers, while maximizing the positive reimbursement environment with remote patient monitoring (RPM) payments now in place. Adherium’s Hailie® digital solution comprises patented sensors and proprietary algorithms that track medication delivery, capturing data for clinicians and generating auditable reimbursement reports for payers and providers. • Most clinical evidence of any digital respiratory monitor (>85 studies involving 13,000 patients) • Clinically proven to improve adherence and outcomes • >170,000 devices sold in 30 countries • Widest US inhaler market coverage • Funded technology upgrade will access US reimbursement